Phase II Study of Neoadjuvant Nivolumab in Patients with Locally Advanced Clear Cell Renal Cell Carcinoma Undergoing Nephrectomy
Maria I. Carlo, Kyrollis Attalla, Yousef Mazaheri, Sounak Gupta, Onur Yıldırım, Samuel Murray, Devyn Taylor Coskey, Ritesh R. Kotecha, Chung‐Han Lee, Darren R. Feldman, Paul Russo, Sujata Patil, Robert J. Motzer, Jonathan Coleman, Jeremy C. Durack, Ying‐Bei Chen, Oğuz Akın, A. Ari Hakimi, Martin H. Voss
Topics & Concepts
MedicineRenal cell carcinomaNivolumabNephrectomyKidney cancerNephrologyAdverse effectSurgeryUrologyKidney diseaseInternal medicineKidneyCancerOncologyImmunotherapyRenal cell carcinoma treatmentBladder and Urothelial Cancer TreatmentsCancer Immunotherapy and Biomarkers